Abstract:BACKGROUND:Survivin is known to be overexpressed in various human malignancies, including pancreatic cancer, and mediates cancer cell proliferation and tumor growth, so the regulation of this molecule could be a new strategy for treating pancreatic cancer. In this study, short hairpin RNAs (shRNAs) specific to survivin were introduced into human pancreatic cancer Patu8988 cells to investigate the inhibitory effects on survivin expression and cell proliferation in vitro and in vivo.METHODS:Three kinds of shRNA specific to the survivin gene were designed and cloned into eukaryotic expression plasmid pGenesil-1 vector. Subsequently the recombinant plasmids were transfected into human pancreatic cancer Patu8988 cells with lipfectamineTM 2000 reagent. The mRNA and protein expressions of survivin in the transiently transfected Patu8988 cells were determined by RT-PCR, flow cytometry, and Western blotting analysis. The proliferation inhibition rates of stably transfected Patu8988 cells were determined by MTT assay. The antitumor activities of the three kinds of survivin-shRNA plasmids were evaluated in BALB/c nude mice inoculated with Patu8988 cells and bearing human pancreatic cancer.RESULTS:The three survivin-shRNA plasmids named pGenesil-1-survivin-1, pGenesil-1-survivin-2 and pGenesil-1-survivin-1+2 (with double interfering RNA sites) were successfully constructed, and were confirmed by restriction enzyme cutting and sequencing. At 48 hours after transfection, the expression of survivin mRNA and protein was inhibited in Patu8988 cells transfected with pGenesil-1-survivin-1, pGenesil-1-survivin-2, and pGenesil-1-survivin-1+2 when compared with that of either pGenesil-1-NC (with scrambled small interfering RNA) transfected cells or control cells (P<0.05). The MTT results showed that the proliferation rates of Patu8988 cells stably transfected with survivin-shRNA plasmids were reduced when compared with that of either pGenesil-1-NC transfected cells or control cells (P<0.01). Furthermore, when Patu8988 cells stably transfected with survivin-shRNA were injected into BALB/c nude mice, tumor growth was dramatically lower and the tumor was smaller than that of either pGenesil-1-NC transfected cells or control cells (P<0.01). The inhibitory effect of pGenesil-1-survivin-1 was the best among the three kinds of survivin-shRNA plasmids, but no combination of inhibitory effects was found in pGenesil-1-survivin-1+2.CONCLUSIONS:shRNAs specific to survivin have gene silencing effects and inhibit pancreatic cancer cell proliferation. shRNA activity against survivin could be of potential value in gene therapy for pancreatic cancer. However, shRNAs with double combining sites did not significantly enhance the interference compared with single site shRNAs, therefore further studies on this are needed.

SiRNA-mediated Survivin Inhibition Enhances Chemo- or Radiosensivity of Colorectal Cancer Cells in Tumor-Bearing Nude Mice.

Effects of selective inactivation of DNA-PKcs gene with small interfering RNA on radiosensitivity of human pancreatic carcinoma cell line

Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity

Survivin Downregulation By Sirna/Cationic Liposome Complex Radiosensitises Human Hepatoma Cells In Vitro And In Vivo

Silencing of Survivin Expression Leads to Reduced Proliferation and Cell Cycle Arrest in Cancer Cells.

Experimental study on the effects of siRNA targeting survivin combined with radiotherapy on human carcinoma cells SW480

Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers

siRNA Directed Against Survivin Enhances Pancreatic Cancer Cell Gemcitabine Chemosensitivity

Silencing Survivin Gene Enhances Radio-Sensitivity of Human Hepatoma SMMC-7721

siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin.

Improved Radiotherapy by Survivin Small Hairpin RNA Trigger Apoptosis of Human Lung Adenocarcinoma Via Caspase-3 Upregulation in Vitro and in Vivo

Enhancement of Cancer Cell Radiosensitivity by Adenovirus Vector Carrying Sirna of Survivin Gene

Anti-tumor Effect of RNA Interference Silencing Survivin Gene Combined with X-ray Irradiation on Human Hepatoma Xenograft in Nude Mice

Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.

Anti-tumor Effect of Silencing HIF-lα and Survivin Genes Combined with Radiotherapy on Human Hepatoma Xenograft in Nude Mice

Effect of enhancing the radiosensitivity of pancreatic cancer cell line PC-2 by siRNA against Survivin.

Silencing Survivin Expression to Induce Apoptosis in Pancreatic Carcinoma Cells by RNA Interference

Growth Inhibition Induced by Short Hairpin RNA to Silence Survivin Gene in Human Pancreatic Cancer Cells.

[Silencing of Survivin Gene Enhances Chemosensitivity of Human Tongue Cancer Cell Line Tca8113 to Cisplatin].